Advertisement
Screener

Assembly Biosciences, Inc. (ASMB) Interest Income, Other

2.8 / 5 stars · 68/120 Roast Me

Assembly Biosciences, Inc. Interest Income, Other

Assembly Biosciences, Inc. (ASMB) reported Interest Income, Other of $2.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Other Income

us-gaap:InterestIncomeOther · last filed 2026-08-13

  • Assembly Biosciences, Inc. interest income, other for the quarter ending 2026-06-30 was $2.49M, a 177.88% increase year-over-year.
  • Assembly Biosciences, Inc. interest income, other for the quarter ending 2026-03-31 was $2.29M, a 104.01% increase year-over-year.
  • Assembly Biosciences, Inc. interest income, other for the quarter ending 2025-12-31 was $2.29M, a 104.37% increase year-over-year.
  • Assembly Biosciences, Inc. interest income, other for the quarter ending 2025-09-30 was $1.69M, a 25.61% increase year-over-year.
  • Assembly Biosciences, Inc. interest income, other for fiscal 2025 was $6.00M, a 7.59% increase from fiscal 2024.
  • Assembly Biosciences, Inc. interest income, other for fiscal 2024 was $5.57M, a 61.49% increase from fiscal 2023.
  • Assembly Biosciences, Inc. interest income, other for fiscal 2023 was $3.45M, a 237.67% increase from fiscal 2022.
  • Assembly Biosciences, Inc. interest income, other for fiscal 2022 was $1.02M, a 238.41% increase from fiscal 2021.
Period endInterest Income, Other 3 monthInterest Income, Other 3 month as first filedInterest Income, Other 6 monthInterest Income, Other 6 month as first filedInterest Income, Other 9 monthInterest Income, Other 9 month as first filedInterest Income, Other 12 monthInterest Income, Other 12 month as first filed
2026-06-30$2.49M
10-Q · filed 2026-08-13
$4.78M
10-Q · filed 2026-08-13
$7.07M
derived: sum of 3 quarters · filed 2026-08-13
$8.76M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$2.29M
10-Q · filed 2026-05-07
$4.58M
derived: sum of 2 quarters · filed 2026-05-07
$6.27M
derived: sum of 3 quarters · filed 2026-05-07
$7.16M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$3.98M
derived: sum of 2 quarters · filed 2026-03-19
$4.87M
derived: sum of 3 quarters · filed 2026-08-13
$6.00M
10-K · filed 2026-03-19
2025-09-30$1.69M
10-Q · filed 2025-11-10
$2.58M
derived: sum of 2 quarters · filed 2026-08-13
$3.71M
10-Q · filed 2025-11-10
$4.83M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$895.00K
10-Q · filed 2026-08-13
$2.02M
10-Q · filed 2026-08-13
$3.14M
derived: sum of 3 quarters · filed 2026-08-13
$4.48M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$1.12M
10-Q · filed 2026-05-07
$2.24M
derived: sum of 2 quarters · filed 2026-05-07
$3.59M
derived: sum of 3 quarters · filed 2026-05-07
$5.04M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$2.46M
derived: sum of 2 quarters · filed 2026-03-19
$3.92M
derived: sum of 3 quarters · filed 2026-03-19
$5.57M
10-K · filed 2026-03-19
2024-09-30$1.34M
10-Q · filed 2025-11-10
$2.80M
derived: sum of 2 quarters · filed 2025-11-10
$4.45M
10-Q · filed 2025-11-10
$6.07M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$1.46M
10-Q · filed 2025-08-06
$3.11M
10-Q · filed 2025-08-06
$4.73M
derived: sum of 3 quarters · filed 2025-08-06
$5.36M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$1.65M
10-Q · filed 2025-05-08
$3.27M
derived: sum of 2 quarters · filed 2025-05-08
$3.90M
derived: sum of 3 quarters · filed 2025-05-08
$4.49M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$1.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$2.25M
derived: sum of 2 quarters · filed 2025-03-20
$2.84M
derived: sum of 3 quarters · filed 2025-03-20
$3.45M
10-K · filed 2025-03-20
2023-09-30$628.00K
10-Q · filed 2024-11-07
$1.22M
derived: sum of 2 quarters · filed 2024-11-07
$1.83M
10-Q · filed 2024-11-07
$2.41M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$592.00K
10-Q · filed 2024-08-08
$1.20M
10-Q · filed 2024-08-08
$1.78M
derived: sum of 3 quarters · filed 2024-08-08
$2.04M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$609.00K
10-Q · filed 2024-05-08
$1.19M
derived: sum of 2 quarters · filed 2024-05-08
$1.45M
derived: sum of 3 quarters · filed 2024-05-08
$1.56M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$583.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$839.00K
derived: sum of 2 quarters · filed 2024-03-28
$951.00K
derived: sum of 3 quarters · filed 2024-03-28
$1.02M
10-K · filed 2024-03-28
2022-09-30$256.00K
10-Q · filed 2023-11-08
$368.00K
derived: sum of 2 quarters · filed 2023-11-08
$439.00K
10-Q · filed 2023-11-08
$540.00K
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$112.00K
10-Q · filed 2023-08-09
$183.00K
10-Q · filed 2023-08-09
$284.00K
derived: sum of 3 quarters · filed 2023-08-09
$356.00K
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$71.00K
10-Q · filed 2023-05-04
$172.00K
derived: sum of 2 quarters · filed 2023-05-04
$244.00K
derived: sum of 3 quarters · filed 2023-05-04
$315.00K
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$101.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$173.00K
derived: sum of 2 quarters · filed 2023-03-22
$244.00K
derived: sum of 3 quarters · filed 2023-03-22
$302.00K
10-K · filed 2023-03-22
2021-09-30$72.00K
10-Q · filed 2022-11-08
$143.00K
derived: sum of 2 quarters · filed 2022-11-08
$201.00K
10-Q · filed 2022-11-08
$425.00K
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$71.00K
10-Q · filed 2022-08-09
$129.00K
10-Q · filed 2022-08-09
$353.00K
derived: sum of 3 quarters · filed 2022-08-09
$1.02M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$58.00K
10-Q · filed 2022-05-12
$282.00K
derived: sum of 2 quarters · filed 2022-05-12
$952.00K
derived: sum of 3 quarters · filed 2022-05-12
$1.64M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$224.00K
10-K · filed 2021-02-25
$894.00K
derived: sum of 2 quarters · filed 2021-11-04
$1.58M
derived: sum of 3 quarters · filed 2021-11-04
$2.62M
10-K · filed 2022-03-11
2020-09-30$670.00K
10-Q · filed 2021-11-04
$1.36M
derived: sum of 2 quarters · filed 2021-11-04
$2.40M
10-Q · filed 2021-11-04
$3.26M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$691.00K
10-Q · filed 2021-08-05
$1.73M
10-Q · filed 2021-08-05
$2.59M
derived: sum of 3 quarters · filed 2021-08-05
$3.57M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$1.04M
10-Q · filed 2021-05-06
$1.90M
derived: sum of 2 quarters · filed 2021-05-06
$2.88M
derived: sum of 3 quarters · filed 2021-05-06
$4.06M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$859.00K
10-K · filed 2021-02-25
$1.84M
derived: sum of 2 quarters · filed 2021-02-25
$3.02M
derived: sum of 3 quarters · filed 2021-02-25
$4.30M
10-K · filed 2021-02-25
$4.30M
10-K · filed 2020-03-04
2019-09-30$983.00K
10-K · filed 2021-02-25
$2.17M
derived: sum of 2 quarters · filed 2021-02-25
$3.45M
10-Q · filed 2020-11-05
$3.44M
10-Q · filed 2019-11-07
$4.51M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$1.18M
10-K · filed 2021-02-25
$2.46M
10-Q · filed 2020-08-05
$2.46M
10-Q · filed 2019-08-05
$3.53M
derived: sum of 3 quarters · filed 2021-02-25
$4.64M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.28M
10-K · filed 2021-02-25
$2.35M
derived: sum of 2 quarters · filed 2021-02-25
$3.46M
derived: sum of 3 quarters · filed 2021-02-25
$3.91M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$1.07M
10-K · filed 2020-03-04
$2.19M
derived: sum of 2 quarters · filed 2020-03-04
$2.64M
derived: sum of 3 quarters · filed 2020-03-04
$3.08M
10-K · filed 2021-02-25
2018-09-30$1.12M
10-K · filed 2020-03-04
$1.12M
10-Q · filed 2018-11-08
$1.57M
derived: sum of 2 quarters · filed 2020-03-04
$2.02M
10-Q · filed 2019-11-07
$2.02M
10-Q · filed 2018-11-08
$2.38M
derived: sum of 4 quarters · filed 2020-03-04
2018-06-30$453.00K
10-K · filed 2020-03-04
$453.02K
10-Q · filed 2018-08-08
$899.00K
10-Q · filed 2019-08-05
$899.42K
10-Q · filed 2018-08-08
$1.26M
derived: sum of 3 quarters · filed 2020-03-04
$1.51M
derived: sum of 4 quarters · filed 2020-03-04
2018-03-31$446.00K
10-K · filed 2020-03-04
$446.41K
10-Q · filed 2018-05-07
$812.00K
derived: sum of 2 quarters · filed 2020-03-04
$1.05M
derived: sum of 3 quarters · filed 2020-03-04
$1.29M
derived: sum of 4 quarters · filed 2020-03-04
2017-12-31$366.00K
10-K · filed 2019-02-28
$365.54K
10-K · filed 2018-03-08
$607.00K
derived: sum of 2 quarters · filed 2019-02-28
$847.00K
derived: sum of 3 quarters · filed 2019-02-28
$983.00K
10-K · filed 2020-03-04
$983.21K
10-K · filed 2018-03-08
2017-09-30$241.00K
10-K · filed 2019-02-28
$241.33K
10-Q · filed 2017-11-01
$481.00K
derived: sum of 2 quarters · filed 2019-02-28
$617.67K
10-Q · filed 2018-11-08
$842.68K
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$240.00K
10-K · filed 2019-02-28
$239.86K
10-Q · filed 2017-08-09
$376.34K
10-Q · filed 2018-08-08
$601.68K
derived: sum of 3 quarters · filed 2019-02-28
$980.06K
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$136.00K
10-K · filed 2019-02-28
$136.48K
10-Q · filed 2017-05-08
$361.68K
derived: sum of 2 quarters · filed 2019-02-28
$740.06K
derived: sum of 3 quarters · filed 2019-02-28
$1.18M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$225.68K
10-K · filed 2018-03-08
$604.06K
derived: sum of 2 quarters · filed 2018-03-08
$1.05M
derived: sum of 3 quarters · filed 2018-03-08
$1.54M
10-K · filed 2019-02-28
$1.54M
10-K · filed 2017-03-02
2016-09-30$378.38K
10-K · filed 2018-03-08
$822.99K
derived: sum of 2 quarters · filed 2018-03-08
$1.31M
10-Q · filed 2017-11-01
$1.77M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$444.61K
10-K · filed 2018-03-08
$935.03K
10-Q · filed 2017-08-09
$1.39M
derived: sum of 3 quarters · filed 2018-03-08
$1.89M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$490.42K
10-K · filed 2018-03-08
$947.07K
derived: sum of 2 quarters · filed 2018-03-08
$1.45M
derived: sum of 3 quarters · filed 2018-03-08
$1.66M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$456.65K
10-K · filed 2017-03-02
$959.33K
derived: sum of 2 quarters · filed 2017-03-02
$1.17M
derived: sum of 3 quarters · filed 2017-03-02
$1.23M
10-K · filed 2018-03-08
2015-09-30$502.68K
10-K · filed 2017-03-02
$713.92K
derived: sum of 2 quarters · filed 2017-03-02
$772.18K
10-Q · filed 2016-11-09
$827.55K
derived: sum of 4 quarters · filed 2017-03-02
2015-06-30$211.23K
10-K · filed 2017-03-02
$269.50K
10-Q · filed 2016-08-09
$324.87K
derived: sum of 3 quarters · filed 2017-03-02
$360.05K
derived: sum of 4 quarters · filed 2017-03-02
2015-03-31$58.27K
10-K · filed 2017-03-02
$113.63K
derived: sum of 2 quarters · filed 2017-03-02
$148.81K
derived: sum of 3 quarters · filed 2017-03-02
$185.68K
derived: sum of 4 quarters · filed 2017-03-02
2014-12-31$55.37K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02
$90.55K
derived: sum of 2 quarters · filed 2017-03-02
$127.42K
derived: sum of 3 quarters · filed 2017-03-02
$167.65K
10-K · filed 2017-03-02
2014-09-30$35.18K
10-Q · filed 2015-11-09
$72.05K
derived: sum of 2 quarters · filed 2015-11-09
$112.29K
10-Q · filed 2015-11-09
$159.30K
derived: sum of 4 quarters · filed 2015-11-09
2014-06-30$36.87K
10-Q · filed 2015-08-13
$77.11K
10-Q · filed 2015-08-13
$124.12K
derived: sum of 3 quarters · filed 2015-08-13
$175.38K
derived: sum of 4 quarters · filed 2015-08-13
2014-03-31$40.23K
10-Q · filed 2015-05-08
$87.25K
derived: sum of 2 quarters · filed 2015-05-08
$138.51K
derived: sum of 3 quarters · filed 2015-05-08
2013-12-31$47.01K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
$98.28K
derived: sum of 2 quarters · filed 2015-03-16
$201.02K
10-K · filed 2015-03-16
2013-09-30$51.27K
10-Q · filed 2014-11-17
$154.01K
10-Q · filed 2014-11-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Evolus, Inc. (EOLS)United States$0.519B-13.32
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53